Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

Drinking coffee is associated with the abundance of the gut bacterium Lawsonibacter asaccharolyticus, demonstrating that ...

Dr Lindsay Rein comments on significant advancements in CML treatment presented at ASH 2024, particularly the approval of asciminib in both the frontline and second-line settings. This new treatment ...

The flavonoid silymarin and one of its structural components, silibinin, are substances with documented hepatoprotective properties. Their mechanisms of action are still poorly understood.

Dr Suchitra Sundaram reflects on how ASH updates will address her patients' questions about the value of MRD testing in CLL treatment.

A cohort study identified a link between COVID-19 and a faster decline in kidney function, especially following ...

An analysis of 6000 cardiac reoperations revealed timing between surgeries did not generally affect operative mortality, ...

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...

Women with metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men ...

Reduced baroreflex sensitivity predicted the risk for dementia linked to hypertension in older adults, beyond what ...

Oxygen therapy saves lives, but does it improve quality of life? Dr Holley explores the balance of benefits, burdens, and ...

A Swedish study found that older adults with celiac disease, particularly women, have a greater risk for frailty than ...